GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹-1,831 Cr | ₹-90 Cr | ₹994 Cr | ₹970 Cr | ₹776 Cr |
What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-90 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹970 Cr |
| Mar2021 | ₹776 Cr |
How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-90 Cr | Negative | |
| Mar2023 | ₹994 Cr | 2.43 | |
| Mar2022 | ₹970 Cr | 25.02 | |
| Mar2021 | ₹776 Cr | - | |
Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,877.8 Cr | 2.9% | 3.4% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.9% |
3.4% |
4.3% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses